Partnering agreements with bigpharma


Published on

Published in: Business, Technology
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Partnering agreements with bigpharma

  1. 1. Partnering Agreements with BigpharmaThe Partnering Agreements with Bigpharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharmacompanies.Partnering Agreements with Bigpharma provides the user with the following key benefits:  Detailed partnering activity profiles for each of the top 50 bigpharma companies  Over 300 charts showing a company’s dealmaking activity since 2007, allowing quick identification potential partners  Partnering therapy focus revealed  Partnering activity since 2007 – number of deals per year  Full listing of partnering deals  Activity by deal type  Activity by industry sector  Activity by phase of development  Activity by technology type  Activity by therapeutic area  Comprehensive access to over 3,000 partnering deals as recorded at Current Agreement, together with contract documents if available  Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents  Understand the key deal terms the company has agreed in previous deals  Undertake due diligence to assess suitability of your proposed deal terms for partner companiesRequest a Sample for or Inquire before buying the report Bigpharma PartneringAgreements ReportPartnering Agreements with Bigpharma is intended to provide the reader with an in-depthunderstanding of the partnering activities of the leading fifty biopharma companiesworldwide, enabling the effective assessment and selection of partners of choice, based onthe latest knowledge of a company’s partnering.Partnering Agreements with Bigpharma includes:  Detailed company profiles for each of the top 50 bigpharma companies, including:  Partnering interests and indications  Partnering activity since 2007  Partner companies since 2007  Partnering activity since 2007 by:  Partner company  Deal type  Industry sector  Stage of development  Technology type  Therapy area
  2. 2.  Over 300 charts showing the dealmaking activity of each company since 2007  The tools to enable effective and efficient preparation for partnering negotiation with bigpharma  3,000 partnering deals as recorded at Current Agreement, together with contract documents if available  The leading M&A and partnering deals by value 2007-2012Major points covered in Table of Contents of this report include:  Executive Summary  Chapter 1 – Introduction  Chapter 2 – Bigpharma top 50 dealmaking activity  Chapter 3 – Top bigpharma deals by value  Chapter 4 – Submitting Opportunities to Bigpharma  Chapter 5 – Forthcoming bigpharma partnering events  Chapter 6 – Bigpharma Company Profiles  Chapter 7 – Resources  Appendices  List of FiguresExplore Reports related to Biotechnology @ Details:Published: February 2012No. of Pages: 712Price: US$2695Contact:Priyank Tiwari7557 Rambler road,Suite 727, Dallas, TX 75231Tel: +1-888-391-5441sales@reportsandreports.comVisit our Market Research Blog @ With Us: